Is the pH of vancomycin an indication for central venous access?

Journal of Vascular Access

Volumn 15, Issue 4, 2014, Pages 249-250

  Moureau, Nancy L ^a,b  

^a PICC Excellence Inc   (United States)

^b Children's Hospital   (United States)

Author keywords

Central venous; Complications; Deep vein thrombosis; Intravenous catheter; Midline; Vancomycin

Indexed keywords

VANCOMYCIN; ANTIINFECTIVE AGENT;

BLOODSTREAM INFECTION; CATHETER INFECTION; CENTRAL VENOUS CATHETER; DECISION MAKING; DEEP VEIN THROMBOSIS; EDITORIAL; EXTRAVASATION; HUMAN; LUNG EMBOLISM; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; OSMOLARITY; PARENTERAL NUTRITION; PERIPHERALLY INSERTED CENTRAL VENOUS CATHETER; PH; PHLEBITIS; VASCULAR ACCESS; CATHETERIZATION; CENTRAL VENOUS CATHETERIZATION; DEVICES; FEMALE; INDWELLING CATHETER; MALE; UPPER LIMB; VASCULARIZATION;

ANTI-BACTERIAL AGENTS; CATHETERIZATION, CENTRAL VENOUS; CATHETERIZATION, PERIPHERAL; CATHETERS, INDWELLING; CENTRAL VENOUS CATHETERS; FEMALE; HUMANS; MALE; UPPER EXTREMITY; VANCOMYCIN;

EID: 84905270549     PISSN: 11297298     EISSN: None     Source Type: Journal    
DOI: 10.5301/jva.5000223     Document Type: Editorial

References (13)

1. Chopra V, Flanders SA, Saint S. The problem with peripherally inserted central catheters. JAMA. 2012;308(15): 1527-1528.
2. Chopra V, O'Horo JC, Rogers MAM, et al. The risk of bloodstream infection associated with peripherally inserted central catheters compared with central venous catheters in adults: a systematic review and meta-analysis. Infect Control Hosp Epidemiol. 2103;34(9):908-918.
3. Evans RS, Sharp JH, Linford LH, et al. Risk of symptomatic DVT associated with peripherally inserted central catheters. Chest. 2010;138(4):803-810.
4. Bonizzoli M, Batacchi S, Cianchi G, et al. Peripherally inserted central venous catheters and central venous catheters related thrombosis in post-critical patients. Intensive Care Med. 2011;37(2):284-289.
5. Maki DG, Kluger DM, Crnich CJ. The risk of bloodstream infection in adults with different intravascular devices: asystematic review of 200 published prospective studies. Mayo Clin Proc. 2006;81(9):1159-1171.
6. Safdar N, Maki DG. Risk of catheter-related bloodstream infection with peripherally inserted central venous catheters used in hospitalized patients. Chest. 2005;128(2):489-495.
7. Gorski LA, Eddins J, Hadaway L, et al. Infusion nursing standards of practice, revised 2011. Infusion Nursing. 2011;24(15):S1-S110.
8. Caparas JV, Hu JP. Safe administration of vancomycin through a novel midline catheter: a randomized, prospective clinical trial. J Vasc Access. 2014;15(4):251-256.
9. O'Grady NP, Alexander M, Burns LA, et al. CDC Guidelines for the Prevention of Intravascular Catheter-Related Infections, 2011.
10. Rybak M, Lomaestro B, Rotschafer JC, et al. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm. 2009;66(1):82-98.
11. Roszell S, Jones C. Intravenous administration issues. JIN. 2010;33(2):112-118.
12. Lanbeck P, Odenholt I, Paulsen O. Antibiotics differ in their tendency to cause infusion phlebitis: a prospective observational study. Scand J Infect Dis. 2002;34(7): 512-519.
13. Mowry JL, Hartman LS. Intravascular thrombophlebitis related to the peripheral infusion of amiodarone and vancomycin. West J Nurs Res. 2011;33(3):457-471.